Treatment for visceral leishmaniasis.
Thakur
C P
CP
D000493:Allopurinol / Q000627:therapeutic use; D000578:Amidines / Q000627:therapeutic use*; D000818:Animals; D000967:Antimony Sodium Gluconate / Q000031:analogs & derivatives / Q000627:therapeutic use*; D005942:Gluconates / Q000627:therapeutic use*; D006019:Glycolysis; D007891:Leishmania / Q000187:drug effects / Q000378:metabolism*; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000378:metabolism; D050356:Lipid Metabolism; D010419:Pentamidine / Q000627:therapeutic use*
D000578:Amidines; D005942:Gluconates; D000493:Allopurinol; D010419:Pentamidine; D000967:Antimony Sodium Gluconate